Strategic Partnerships As a small, private innovator with a next-generation transcatheter aortic valve, there is a strong opportunity to pursue co-development, licensing, or distribution partnerships with larger medtech players to scale regulatory approval, manufacturing, and market access.

Clinical Proof Prioritize building robust clinical data on durability across patient subgroups and establish physician training programs and pilot studies to create a compelling value proposition for cardiologists and surgeons.

Adoption Focus Target high-volume TAVI centers and early adopters to perform initial implants, generate real-world experience, and create persuasive references that leverage the founder's expertise in the aortic valve field.

Global Expansion With early-stage funding and limited revenues, plan international expansion through distributors and partnerships once regulatory pathways are clarified, enabling entry into European and other markets.

Competitive Positioning Position the offering as a durable, broadly applicable solution addressing unmet needs in aortic stenosis to differentiate from incumbents, and craft messaging around long-term outcomes and patient care continuity.